ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Shire
November 11 2013 - 12:17PM
Business Wire
Former United States Securities and Exchange Commission attorney
Willie Briscoe and the securities litigation firm of Powers Taylor
LLP are investigating potential claims against the Board of
Directors of ViroPharma Inc. (“ViroPharma”) (NasdaqGS: VPHM)
related to the acquisition by Shire PLC for shareholders. Under the
terms of the proposed transaction valued at approximately $4.2
billion, ViroPharma shareholders will only receive $50.00 in cash
for each share owned.
If you are an affected investor, and you want to learn more
about the lawsuit or join the action, contact Willie Briscoe at The
Briscoe Law Firm, PLLC, (214) 239-4568, or via email at
WBriscoe@TheBriscoeLawFirm.com, or Zach Groover at Powers Taylor
LLP, toll free (877) 728-9607, via e-mail at
shareholder@powerstaylor.com. There is no cost or fee to you.
The ViroPharma investigation centers on whether ViroPharma’s
Board of Directors is acting in the shareholders’ best interests,
whether the board is properly considering the proposed price for
the shareholders, and whether the board has employed an adequate
process to review and act on the proposed transaction.
The Briscoe Law Firm, PLLC is a full service business litigation
and shareholder rights advocacy firm with more than 20 years of
experience in complex litigation and transactional matters.
Powers Taylor LLP is a boutique litigation law firm that handles
a variety of complex business litigation matters, including claims
of investor and stockholder fraud, shareholder oppression,
shareholder derivative suits, and security class actions.
The Briscoe Law Firm, PLLCWillie Briscoe,
214-239-4568WBriscoe@TheBriscoeLawFirm.comorPowers Taylor LLPZach
Groover, 877-728-9607shareholder@powerstaylor.com
Viropharma Incorporated (MM) (NASDAQ:VPHM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Viropharma Incorporated (MM) (NASDAQ:VPHM)
Historical Stock Chart
From Jul 2023 to Jul 2024